Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation https://t.co/1hAvbvNGRc #hvhebron #nefro [Text complet]
2,364 followers
685 followers
RT @Transpl_Int: Antibody-Mediated Rejection endpoints in #KidneyTransplant clinical trials must be a combination of #histopathology factor…
8,175 followers
RT @Transpl_Int: Antibody-Mediated Rejection endpoints in #KidneyTransplant clinical trials must be a combination of #histopathology factor…
861 followers
RT @Transpl_Int: Antibody-Mediated Rejection endpoints in #KidneyTransplant clinical trials must be a combination of #histopathology factor…